In 2014, the PSA threshold in this guideline was lowered from 4 ng/mL to 3 ng/mL to be consistent with the national guideline on prostate cancer issued by the Dutch Urological Association (Nederlandse Vereniging voor Urologie) [19, 24]. Here, KLK3 is linked to prostate cancer.